Prostate Cancer Imaging Market Size
The Prostate Cancer Imaging Market is estimated to reach USD 1,077.8 Million in 2025 and is projected to grow to USD 1,679.0 Million by 2033, registering steady growth at a CAGR of 5.70% during the forecast period from 2026 to 2033.
The rising prevalence of prostate cancer is driving the demand for imaging devices. For instance, according to the National Cancer Institute, in the U.S., around 174,650 new cases were diagnosed in 2019. Also, increasing technological advancements in imaging devices are expected to further fuel market growth over the forecast period. According to the research report, the global market is divided into five major regions such as North America, Europe, Latin America, Asia Pacific, the Middle East and Africa, and the Rest of the world. Among all regions, the North American region has the highest share in the global market share, and it is continuing its dominance over the forecast period 2024-2031. The Asia Pacific region is expected to produce the fastest growth rate over the forecast period 2024-2031.
Market Summary
| Metrics | Details |
| Market CAGR | 5.70% |
| Segments Covered | By Type, By Solution, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Prostate Cancer Imaging Market Dynamics
Increasing Prevalence of Prostate Cancer.
The increasing prevalence of prostate cancer is one of the important factors, which is expected to boost the growth of the market throughout the forecast. Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. based on GLOBOCAN 2018 estimates, 1,276,106 new cases of prostate cancer were reported worldwide in 2018, with a higher prevalence in developed countries.
Increasing Old Aged Male Population
The increasing old-aged male population is one of the main factors, which can be responsible for boosting the growth of the global prostate cancer imaging market. The global population aged 60 years or over numbered 962 million in 2017, more than twice as large as in 1980 when there were 382 million older persons worldwide. The male geriatric population is prone to prostate cancer, hence, the increasing old-aged male population is responsible for the significant growth of the global prostate cancer market.
Major Global Players
The major global players in Prostate Cancer Imaging market include GE Healthcare, Siemens Healthineers, Philips, Focal Healthcare, Telix, Quibim, Promaxo, Lucida Medical, Exact Imaging, Koelis.
Recent Developments 2026
- April 2026 – Siemens Healthineers and GE Healthcare advancing AI-based prostate imaging
Siemens Healthineers and GE Healthcare enhanced MRI and PET imaging platforms with AI-driven analysis to improve early detection and accurate staging of prostate cancer. - March 2026 – Philips and Exact Imaging expanding precision ultrasound and MRI fusion systems
Philips and Exact Imaging strengthened imaging solutions combining ultrasound and MRI fusion to improve biopsy guidance and diagnostic accuracy in prostate cancer screening. - February 2026 – Telix and Quibim advancing molecular imaging innovations
Telix Pharmaceuticals and Quibim developed advanced molecular imaging tools and radiotracers to improve visualization of prostate tumors and support targeted treatment planning. - January 2026 – Growth in image-guided biopsy and navigation systems
Companies such as Focal Healthcare, Promaxo, Lucida Medical, and Koelis expanded AI-assisted biopsy guidance and real-time navigation systems to improve clinical precision and reduce diagnostic errors.
